leisure time -WSS

leisure time

author：fashion 2025-09-29 19:06:13 - browse：397

Terry Horgan pictured at home -- coverage from STAT — Terry Horgan in his family's Montour Falls, N.Y., home, in an undated photo. Kate Collins/The Journal via AP

Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation.

Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.

These viruses, known as adeno-associated viruses, or AAVs, are used in several approved drugs and hundreds of clinical trials to deliver genes into patients, because they are generally benign. But at high doses they can cause side effects and, occasionally, deaths through one of several mechanisms, such as directly injuring the liver or triggering a type of immune response known as complement activation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： New documents shed light on MD Anderson Cancer Institute feud

knowledge

focus

WSS

Dogs on Prozac: What pet anti

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Alabama frozen embryo ruling has major implications for IVF clinics

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Element Biosciences CEO lays out genome sequencing strategy

After traumatic brain injury, life support decisions can use more time

leisure time

leisure time

focus

Anesthesiologist group: stop taking Ozempic before surgery

STAT readers on older presidents, polypills, Medicare, and more

Supreme Court strikes down use of affirmative action

Alabama IVF ruling threatens families facing fatal genetic disease

Virginia high school admissions case could be legal follow

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

In age of alternative facts, a scholarly course on calling out crap

After traumatic brain injury, life support decisions can use more time

Peter Hotez and the public health issue of online harassment

He's a Nobel laureate. Critics say he was misleading on Covid

focus

Medical bills so high, Medicare adding extra digits to claim forms

Why does health care cost so much? A reading guide

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

New documents shed light on MD Anderson Cancer Institute feud

Close Medicare's dangerous gaps in addiction treatment coverage

PBM reform efforts get punted in Congress

knowledge

explore

focus

hotspot